|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4704 | |
| A61K 31/221 | |||
| A61K 31/255 | |||
| A61K 31/445 | |||
| A61K 31/473 | |||
| A61P 43/00 |
| (11) | Patento numeris | 1853265 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06733984.6 |
| Europos patento paraiškos padavimo data | 2006-01-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-11-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2016-01-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2006/002977 |
| Data | 2006-01-27 |
| (87) | Numeris | WO 2006/081444 |
| Data | 2006-08-03 |
| (30) | Numeris | Data | Šalis |
| 648307 P | 2005-01-28 | US | |
| 707192 P | 2005-08-09 | US |
| (72) |
GORDON, Leslie, B., US
COLLINS, Francis, S., US
GLOVER, Thomas, US
GLYNN, Michael, W., US
CAPELL, Brian, C., US
COX, Adrienne, D., c/o Dept. Radiation Oncology, US
DER, Channing, J., c/o Lineberger Comp.Cancer Ctr., US
|
| (73) |
THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL,
Office of Technology Development, Campus Box 4105, 308 Bynum Hall, Chapel Hill, NC 27599-4105,
US
The Government of the United States of America as represented by the Secretary of the Department of Health and Human S, National Institutes of Health, Suite 325, 6011 Executive Boulevard, Rockville, MD 20852-3804, US The Progeria Research Foundation, Inc., P.O. Box 3453, Peabody, MA 01961-3453, US THE REGENTS OF THE UNIVERSITY OF MICHIGAN, Wolverine Tower Room 2071, 3003 South State Street, Ann Arbor, Michigan 48109-1290, US |
| (54) | FARNESYLTRANSFERASE INHIBITORS FOR USE IN THE TREATMENT OF LAMINOPATHIES, CELLULAR AGING AND ATHEROSCLEROSIS |
| FARNESYLTRANSFERASE INHIBITORS FOR USE IN THE TREATMENT OF LAMINOPATHIES, CELLULAR AGING AND ATHEROSCLEROSIS |